Arizona has had a statewide Task Force on Preventing Prenatal Exposure to Alcohol and Other Drugs since 2005. This is the website for the task force which includes information about the risks of substance use during pregnancy and some resources and contact information.
This Spanish language 2 page patient information guide provides information about the risks of taking common drugs or medications including opioids during pregnancy. Part of the Arizona ReThink RX Abuse initiative which helps communities educate their citizens about prescription drug safety.
This 2 page patient information guide provides information about the risks of taking common drugs or medications including opioids during pregnancy. Part of the Arizona ReThink RX Abuse initiative which helps communities educate their citizens about prescription drug safety.
The Arizona Substance Abuse Task Force produced this 2016 report recommending policy changes to address the opioid crisis. Topics covered included identifying evidence based treatments, improving access to substance use disorder treatment, focusing on prevention and early
The Arizona Department of Health Services created these frequently asked questions to explain the state requirement that health care providers report cases of neonatal opioid withdrawal (or neonatal abstinence syndrome) as part of the state’s enhanced opioid surveillance.
This 4 page briefing paper provides information for dentists about prescribing opioids for women of reproductive age and women who are pregnant. It includes information about neonatal opioid withdrawal syndrome and provides guidelines for prescribing opioids for dental care providers. A six page version is also available.
This report summarizes findings from two studies from 2017 that looked at risk factors associated with the development of neonatal withdrawal syndrome (also known as neonatal abstinence syndrome) in babies born to mothers with opioid use disorder. Published in the National Institute on Drug Abuse research notes.
This 2018 report from the National Academy for State Health Policy describes strategies state and local leaders can adopt to promote recovery among pregnant and parenting women with opioid use disorder. It also features descriptions of programs in place in Colorado, Pennsylvania, and Texas.
This guide from the National Institute on Drug Abuse addresses treating opioid use disorder (OUD) during pregnancy. It includes information about the effects of OUD on unborn children and newborns and about the benefits of medication assisted treatment for pregnant women with OUD diagnoses.
This one page infographic from the National Institute on Drug Abuse shows the occurrence of neonatal withdrawal syndrome (also known as neonatal abstinence syndrome) in babies born in the United States between 2004 and 2014.